Cargando…

COVID-19: benefits and risks of passive immunotherapeutics

Passive immunotherapeutics (PITs), including convalescent plasma, serum, or hyperimmune immunoglobulin, have been of clinical importance during sudden outbreaks since the early twentieth century for the treatment of viral diseases such as severe acute respiratory syndrome (SARS), middle east respira...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gupta, Ankur, Karki, Rashmi, Dandu, Himanshu R, Dhama, Kuldeep, Bhatt, Madan LB, Saxena, Shailendra K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Mini-Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7544960/ https://www.ncbi.nlm.nih.gov/pubmed/32962524 http://dx.doi.org/10.1080/21645515.2020.1808410

Ejemplares similares

Recombinant vaccines for COVID-19
por: Yadav, Tushar, et al.
Publicado: (2020)

Plant-based vaccines and antibodies to combat COVID-19: current status and prospects
por: Dhama, Kuldeep, et al.
Publicado: (2020)

Current Insight into the Novel Coronavirus Disease 2019 (COVID-19)
por: Saxena, Shailendra K., et al.
Publicado: (2020)

Exploring the possible use of saponin adjuvants in COVID-19 vaccine
por: Sharma, Rinku, et al.
Publicado: (2020)

Recent Advances in Toxoplasma gondii Immunotherapeutics
por: Lim, Sherene Swee-Yin, et al.
Publicado: (2014)

Global scenario, public health concerns and mitigation strategies to counter current ongoing SARS-CoV-2 / COVID-19 pandemic
por: Barbuddhe, Sukhadeo Baliram, et al.
Publicado: (2020)

Environmental Health Risks After the 2023 Turkey-Syria Earthquake and Salient Mitigating Strategies: A Critical Appraisal
por: Ahmed, Sirwan Khalid, et al.
Publicado: (2023)

COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics
por: Dhama, Kuldeep, et al.
Publicado: (2020)

Multi-peptide immunotherapeutic vaccine for renal cell carcinoma: getting the troops all worked up
por: Yaddanapudi, Kavitha, et al.
Publicado: (2012)

BCG vaccine: a hope to control COVID-19 pandemic amid crisis
por: Malik, Yashpal Singh, et al.
Publicado: (2020)

COVID-19 intranasal vaccines: current progress, advantages, prospects, and challenges
por: Dhama, Kuldeep, et al.
Publicado: (2022)

Recent advances in vaccine and immunotherapy for COVID-19
por: Rabaan, Ali A., et al.
Publicado: (2020)

Complicated case of COVID-19 disease with overlapping features of thrombotic thrombocytopenic purpura and haemophagocytic lymphohistiocytosis
por: Verma, Durga Prasad, et al.
Publicado: (2021)

An Ophthalmological update for air-travellers during COVID-19
por: Pandey, Nitika, et al.
Publicado: (2021)

Immunomodulation and immunotherapeutics of COVID-19
por: Garg, Sourbh Suren, et al.
Publicado: (2021)

Macro and trace mineral constituents and radionuclides in mushrooms: health benefits and risks
por: Falandysz, Jerzy, et al.
Publicado: (2012)

Therapeutic Development and Drugs for the Treatment of COVID-19
por: Maurya, Vimal K., et al.
Publicado: (2020)

Respiratory delivery of passive immunotherapies for SARS-CoV-2 prophylaxis and therapy
por: Focosi, Daniele, et al.
Publicado: (2023)

Mesenchymal stem cells as a therapeutic approach to glomerular diseases: benefits and risks
por: Kunter, Uta, et al.
Publicado: (2011)

Clinical management, antiviral drugs and immunotherapeutics for treating monkeypox. An update on current knowledge and futuristic prospects
por: Chakraborty, Sandip, et al.
Publicado: (2022)

Immunotherapies and immunomodulatory approaches in clinical trials - a mini review
por: Iqbal Yatoo, Mohd., et al.
Publicado: (2021)

Passive immunization of the human vagina
por: Anderson, Deborah J.
Publicado: (2021)

Collateral benefits of studying the vagus nerve in bioelectronic medicine
por: Pavlov, Valentin A.
Publicado: (2019)

Methanol poisoning: characteristic MRI findings
por: Jain, Nirdesh, et al.
Publicado: (2013)

COVID-19: immunopathogenesis and Immunotherapeutics
por: Yang, Li, et al.
Publicado: (2020)

Azospirillum: benefits that go far beyond biological nitrogen fixation
por: Fukami, Josiane, et al.
Publicado: (2018)

Potential Health-Promoting Benefits of Paraprobiotics, Inactivated Probiotic Cells
por: Akter, Shahina, et al.
Publicado: (2020)

Bariatric Surgery: Remission of Inflammation, Cardiometabolic Benefits, and Common Adverse Effects
por: Biobaku, Fatimo, et al.
Publicado: (2020)

Review of potential risk groups for coronavirus disease 2019 (COVID-19)
por: Naveed, M., et al.
Publicado: (2021)

Diabetes and COVID-19: evidence, current status and unanswered research questions
por: Gupta, Ritesh, et al.
Publicado: (2020)

Hepatocellular Carcinoma Surveillance: Benefit of Serum Alfa-fetoprotein in Real-world Practice
por: Lersritwimanmaen, Patharapan, et al.
Publicado: (2018)

Mutated COVID-19 may foretell a great risk for mankind in the future
por: Dawood, A.A.
Publicado: (2020)

Enhanced rock weathering: biological climate change mitigation with co-benefits for food security?
por: Beerling, David J.
Publicado: (2017)

COVID-19 associated Mucormycosis among ICU patients: risk factors, control, and challenges
por: Abd El-Baky, Rehab Mahmoud, et al.
Publicado: (2023)

Plasma therapy: a passive resistance against the deadliest
por: Hansda, Anita, et al.
Publicado: (2021)

Immunotherapeutic approaches to curtail COVID-19
por: Owji, Hajar, et al.
Publicado: (2020)

Dexamethasone to combat cytokine storm in COVID-19: Clinical trials and preliminary evidence
por: Sharun, Khan, et al.
Publicado: (2020)

Comparative evaluation of adverse drug reaction reporting forms for introduction of a spontaneous generic ADR form
por: Singh, Anshi, et al.
Publicado: (2012)

COVID-19 Vaccine Diplomacy and Equitable Access to Vaccines Amid Ongoing Pandemic
por: Sharun, Khan, et al.
Publicado: (2021)

Our children are at risk of COVID-19- associated rhino-orbito-cerebral mucormycosis (ROCM)
por: Saied, AbdulRahman A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_basrogffij5iam24eppgn26gpb